Fineotex Chemical completed its preferential warrant exercise on 21 November 2025, allotting equity shares to promoter and non-promoter investors. The strong promoter participation signals confidence in FCL's strategic direction, robust operations and expansion plans, with funds allocated to working capital and potential strategic acquisitions. This move reinforces long-term value creation.